Comparing three different techniques for magnetic resonance imaging-targeted prostate biopsies: a systematic review of in-bore versus magnetic resonance imaging …

O Wegelin, HHE van Melick, L Hooft, JLHR Bosch… - European urology, 2017 - Elsevier
Context The introduction of magnetic resonance imaging-guided biopsies (MRI-GB) has
changed the paradigm concerning prostate biopsies. Three techniques of MRI-GB are …

American Cancer Society guideline for the early detection of prostate cancer: update 2010

AMD Wolf, RC Wender, RB Etzioni… - CA: a cancer journal …, 2010 - Wiley Online Library
Abstract In 2009, the American Cancer Society (ACS) Prostate Cancer Advisory Committee
began the process of a complete update of recommendations for early prostate cancer …

Low-cost thermophoretic profiling of extracellular-vesicle surface proteins for the early detection and classification of cancers

C Liu, J Zhao, F Tian, L Cai, W Zhang, Q Feng… - Nature biomedical …, 2019 - nature.com
Non-invasive assays for early cancer screening are hampered by challenges in the isolation
and profiling of circulating biomarkers. Here, we show that surface proteins from serum …

Long noncoding RNAs as novel biomarkers have a promising future in cancer diagnostics

T Shi, G Gao, Y Cao - Disease markers, 2016 - Wiley Online Library
Cancers have a high mortality rate due to lack of suitable specific early diagnosis tumor
biomarkers. Emerging evidence is accumulating that lncRNAs (long noncoding RNAs) are …

A rich array of prostate cancer molecular biomarkers: opportunities and challenges

I Kohaar, G Petrovics, S Srivastava - International journal of molecular …, 2019 - mdpi.com
Prostate cancer is the most prevalent non-skin cancer in men and is the leading cause of
cancer-related death. Early detection of prostate cancer is largely determined by a widely …

Prostate-specific–antigen testing for early diagnosis of prostate cancer

MJ Barry - New England Journal of Medicine, 2001 - Mass Medical Soc
Foreword This Journal feature begins with a case vignette highlighting a common clinical
problem. Evidence supporting various strategies is then presented, followed by a review of …

Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy

A Haese, A de la Taille, H Van Poppel, M Marberger… - European urology, 2008 - Elsevier
BACKGROUND: The Prostate CAncer gene 3 (PCA3) assay has shown promise as an aid in
prostate cancer (pCA) diagnosis in identifying men with a high probability of a positive …

Clinical validation of an epigenetic assay to predict negative histopathological results in repeat prostate biopsies

AW Partin, L Van Neste, EA Klein, LS Marks… - The Journal of …, 2014 - auajournals.org
Purpose: The DOCUMENT multicenter trial in the United States validated the performance of
an epigenetic test as an independent predictor of prostate cancer risk to guide decision …

Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop?

BOB Djavan, V Ravery, A Zlotta, P Dobronski… - The Journal of …, 2001 - auajournals.org
Purpose: We evaluated biochemical parameters and pathological features, as well as
biopsy related morbidity of prostate cancer detected on biopsies 2, 3 and 4 in men with total …

Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care

JI Epstein, M Herawi - The Journal of urology, 2006 - Elsevier
PURPOSE: We identified information critical for patient treatment on prostate needle
biopsies diagnosed with prostatic intraepithelial neoplasia or atypical foci suspicious for …